You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 5, May 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992

C. C. Chan, R. G. Roberge, S. M. Whitcup and R. B. Nussenblatt
Laboratory of Immunology and Clinical Branch, National Eye Institute, Bethesda, Md., USA.

OBJECTIVE: To examine the relationship between visual outcome and the clinical management of patients with sympathetic ophthalmia. METHODS: Thirty-two patients with sympathetic ophthalmia who were seen at the National Eye Institute, Bethesda, Md, between 1982 and 1992, were retrospectively reviewed. RESULTS: There were equal numbers of males and females. Sympathetic ophthalmia occurred after trauma in 23 patients and surgery in nine patients. Sixteen of the 32 patients had a final visual acuity of 20/40 or better; 10 patients had a visual acuity worse than 20/200. Good visual outcome was associated with early and aggressive treatment with corticosteroids, sometimes in combination with other immunosuppressive agents. Poor visual acuity was associated with glaucoma, chorioretinal scars in the macula, and persistent uncontrolled inflammation. CONCLUSION: Prompt and aggressive use of antiinflammatory therapy can improve the visual outcome of patients with sympathetic ophthalmia.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unremitting sympathetic ophthalmia associated with homozygous interleukin-10-1082A single nucleotide polymorphism
Glover et al.
Br. J. Ophthalmol. 2008;92:155-156.
FULL TEXT  

UK national survey of enucleation, evisceration and orbital implant trends
Viswanathan et al.
Br. J. Ophthalmol. 2007;91:616-619.
ABSTRACT | FULL TEXT  

Cytokine Gene Polymorphism in Sympathetic Ophthalmia
Atan et al.
IOVS 2005;46:4245-4250.
ABSTRACT | FULL TEXT  

Penetrating ocular injuries in previously injured blind eyes: should we consider primary enucleation?
Hollander et al.
Br. J. Ophthalmol. 2004;88:438-438.
FULL TEXT  

Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients
Kilmartin et al.
Br. J. Ophthalmol. 2001;85:281-286.
ABSTRACT | FULL TEXT  

Sympathetic ophthalmia risk following vitrectomy: should we counsel patients?
KILMARTIN et al.
Br. J. Ophthalmol. 2000;84:448-449.
FULL TEXT  

Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland
Kilmartin et al.
Br. J. Ophthalmol. 2000;84:259-263.
ABSTRACT | FULL TEXT  

Sympathetic contralateral vestibulopathy after unilateral zoster oticus
Schulz et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:672-676.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.